SCHEMBL2020663

SCHEMBL2020663

O=S(=O)(Cl)CCBr

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3618484 0.80
SCHEMBL6983172 0.78
SCHEMBL1931721 0.76 APLNR (0.35)
SCHEMBL7102336 0.76
SCHEMBL7100692 0.76
SCHEMBL2587995 0.76
SCHEMBL7101296 0.76
SCHEMBL7102275 0.76
SCHEMBL7098348 0.76
SCHEMBL7098330 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119119538-A Method for modifying high-barrier PVA composite film by using bamboo shoot shells 安徽省农业科学院农产品加工研究所 2024-12-13 CN claimed
CN-115399179-B Application of polysaccharide-based cationic polymer in preventing and controlling soil-borne diseases of agriculture and forestry 中国科学院化学研究所 2024-10-29 CN claimed
CN-115399179-A Application of polysaccharide-based cationic polymer in prevention and treatment of soil-borne diseases of agriculture and forestry 中国科学院化学研究所 2022-11-29 CN claimed
CN-107586267-B Synthetic method of taurine hydrochloride (2-amino ethyl taurine hydrochloride) 华东师范大学 2020-02-18 CN claimed
CN-107586267-A A kind of synthetic method of tauryl amine hydrochlorate (2 aminoethyl sulfanylamide hydrochloride) 华东师范大学 2018-01-16 CN claimed
EP-4743178-A1 NOVEL COMPOUNDS FOR THE TREATMENT OF CANCER AND METABOLIC DISEASES Katholieke Universiteit Leuven KU Leuven Research & Development (BE) 2026-05-20 EP disclosed
EP-4743447-A1 NOVEL COMPOUNDS FOR THE TREATMENT OF CANCER AND METABOLIC DISEASES Katholieke Universiteit Leuven KU Leuven Research & Development (BE) 2026-05-20 EP disclosed
WO-2025016909-A1 NOVEL COMPOUNDS FOR THE TREATMENT OF CANCER AND METABOLIC DISEASES KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2025-01-23 WO disclosed
WO-2025016906-A1 NOVEL COMPOUNDS FOR THE TREATMENT OF CANCER AND METABOLIC DISEASES KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2025-01-23 WO disclosed
CN-119119538-A Method for modifying high-barrier PVA composite film by using bamboo shoot shells 安徽省农业科学院农产品加工研究所 2024-12-13 CN disclosed
CN-115399179-B Application of polysaccharide-based cationic polymer in preventing and controlling soil-borne diseases of agriculture and forestry 中国科学院化学研究所 2024-10-29 CN disclosed
CN-112384509-B Furin inhibitors 葛兰素史密斯克莱知识产权发展有限公司 2024-04-30 CN disclosed
EP-1020443-A1 PROCESS FOR PRODUCING PIPERAZINESULFONAMIDE DERIVATIVES AND SALTS THEREOF Azwell Inc. (JP) 2000-07-19 EP disclosed
EP-0788509-A4 THERAPEUTIC PEPTIDE DERIVATIVES BIOMEASURE INC (US) 1999-07-14 EP disclosed
EP-0788509-A1 THERAPEUTIC PEPTIDE DERIVATIVES BIOMEASURE, INC. (US) 1997-08-13 EP disclosed
US-5552520-A Such as somatostatin analogs or bombesin analogs BIOMEASURE, INC. (US) 1996-09-03 US disclosed
WO-1995004752-A1 THERAPEUTIC PEPTIDE DERIVATIVES BIOMEASURE, INC. (US) 1995-02-16 WO disclosed
EP-0592306-A2 19F-MRI Contrast medium TERUMO KABUSHIKI KAISHA (JP) 1994-04-13 EP disclosed
US-4444694-A Preparation of 2-aminoalkanesulfonic acid THE DOW CHEMICAL COMPANY (US) 1984-04-24 US disclosed
US-4136253-A ANTIBIOTICS PFIZER INC. (US) 1979-01-23 US disclosed